Radioactive 'Smart Bomb' targets Hard-to-Treat brain tumors

NCT ID NCT07150806

First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 2 times

Summary

This study tests a new drug called RYZ101 for people with meningioma that has come back or is growing despite standard treatments. RYZ101 is a radioactive substance that targets a protein found on these tumor cells, aiming to kill them while sparing healthy tissue. The trial will check the drug's safety, find the best dose, and see if it can stop the tumor from growing. It is for adults whose tumors show up on a specific PET scan and who have already tried surgery or radiation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRACRANIAL MENINGIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Ohio State University Comprehensive Cancer Center

    RECRUITING

    Columbus, Ohio, 43210, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.